U.S. markets open in 6 hours 9 minutes
  • S&P Futures

    3,378.25
    +26.25 (+0.78%)
     
  • Dow Futures

    27,914.00
    +250.00 (+0.90%)
     
  • Nasdaq Futures

    11,487.00
    +79.75 (+0.70%)
     
  • Russell 2000 Futures

    1,519.00
    +14.60 (+0.97%)
     
  • Crude Oil

    40.26
    +0.04 (+0.10%)
     
  • Gold

    1,904.50
    +9.00 (+0.47%)
     
  • Silver

    23.89
    +0.40 (+1.69%)
     
  • EUR/USD

    1.1751
    +0.0025 (+0.21%)
     
  • 10-Yr Bond

    0.6770
    0.0000 (0.00%)
     
  • Vix

    26.37
    +0.10 (+0.38%)
     
  • GBP/USD

    1.2942
    +0.0021 (+0.16%)
     
  • USD/JPY

    105.4600
    +0.0300 (+0.03%)
     
  • BTC-USD

    10,843.60
    +47.56 (+0.44%)
     
  • CMC Crypto 200

    224.37
    +2.97 (+1.34%)
     
  • FTSE 100

    5,916.29
    +50.19 (+0.86%)
     
  • Nikkei 225

    23,184.93
    -0.19 (-0.00%)
     

Are Institutions Heavily Invested In Meridian Bioscience, Inc.'s (NASDAQ:VIVO) Shares?

Simply Wall St

A look at the shareholders of Meridian Bioscience, Inc. (NASDAQ:VIVO) can tell us which group is most powerful. Institutions often own shares in more established companies, while it's not unusual to see insiders own a fair bit of smaller companies. Companies that used to be publicly owned tend to have lower insider ownership.

Meridian Bioscience has a market capitalization of US$1.0b, so we would expect some institutional investors to have noticed the stock. Our analysis of the ownership of the company, below, shows that institutional investors have bought into the company. Let's delve deeper into each type of owner, to discover more about Meridian Bioscience.

View our latest analysis for Meridian Bioscience

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Meridian Bioscience?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

Meridian Bioscience already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone, since institutions make bad investments sometimes, just like everyone does. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Meridian Bioscience's earnings history, below. Of course, the future is what really matters.

earnings-and-revenue-growth
earnings-and-revenue-growth

Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. Our data indicates that hedge funds own 7.4% of Meridian Bioscience. That worth noting, since hedge funds are often quite active investors, who may try to influence management. Many want to see value creation (and a higher share price) in the short term or medium term. Looking at our data, we can see that the largest shareholder is BlackRock, Inc. with 15% of shares outstanding. In comparison, the second and third largest shareholders hold about 10% and 7.4% of the stock.

We also observed that the top 9 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There is some analyst coverage of the stock, but it could still become more well known, with time.

Insider Ownership Of Meridian Bioscience

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

Shareholders would probably be interested to learn that insiders own shares in Meridian Bioscience, Inc.. The insiders have a meaningful stake worth US$12m. Most would see this as a real positive. It is good to see this level of investment by insiders. You can check here to see if those insiders have been buying recently.

General Public Ownership

With a 16% ownership, the general public have some degree of sway over VIVO. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

Next Steps:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. For example, we've discovered 1 warning sign for Meridian Bioscience that you should be aware of before investing here.

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.